Curexo
Publicly traded South Korean manufacturer of orthopedic and spine surgical robotics.
Updated Jul 1, 2026
Headquartered in South Korea
This profile is compiled from public information and hasn't been claimed yet. Are you part of this company?
Overview
About Curexo
Curexo manufactures orthopedic and spine surgical robotics systems, and is publicly traded, headquartered in Seoul, South Korea.
Products
- Orthopedic & spine surgical robotics
Markets Served
Verification
Verification status
Last verified: Never
History
No verification history yet — this profile has not been claimed or submitted for review.
Verification requirements
Business registration document
A government-issued certificate of incorporation or business license.
Authorized company contact
A named contact with an email at the company's own domain.
Quality certification proof
Evidence of ISO 13485 or equivalent quality management certification.
Product catalog or line cardOptional
A current listing of manufactured product lines.
Why verify
What verification unlocks
Verification is how GHMAP tells buyers a profile is real and current — and how a company moves from being listed to being found first.
| Benefit | VerifiedSelf-service | Premium VerifiedPaid plan | GHMAP PartnerGHMAP-granted | GHMAP CertifiedGHMAP-granted |
|---|---|---|---|---|
| Priority search ranking | ||||
| Lead generation | ||||
| Verification indicators | ||||
| Premium visibility | ||||
| Future marketplace participation |
Related
Certifications
ISO 13485
The international quality management system standard specific to medical device manufacturers, referenced by most major regulators.
View →
CE Mark
The conformity mark required to sell medical devices in the EU/EEA, issued once a device meets EU MDR or IVDR requirements.
View →
FDA 510(k) / PMA
US market authorization for medical devices via the FDA's 510(k), De Novo, or PMA pathways.
View →
Related
Regulatory Pathways
Opportunity Marketplace
Have a distributor search, tender, or other opportunity involving Curexo?
Submit it for GHMAP review — publication happens only after explicit admin approval.
Reviewed launch planning
Ready to connect with Curexo?
GHMAP routes introduction requests through a reviewed process — no cold outreach, no unverified contact details.
Professional review remains part of the workflow.